OTCMKTS:TEAR

TearLab (TEAR) Stock Price, News & Analysis

TearLab logo
$0.06 0.00 (-1.86%)
As of 07/9/2020

About TearLab Stock (OTCMKTS:TEAR)

Key Stats

Today's Range
$0.06
▼
$0.06
50-Day Range
$0.06
▼
$0.06
52-Week Range
$0.02
▼
$0.22
Volume
20,200 shs
Average Volume
N/A
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

TearLab Corporation develops diagnostic technology for eye care professionals, with a focus on assessing dry eye disease. Its products are designed to provide point-of-care measurements that can support clinical evaluation of patients with dry eye symptoms.

The company’s TearLab Osmolarity System measures the osmolarity of a small tear-fluid sample. The system combines a reader with disposable test cards, allowing testing to be performed in an eye care setting.

TearLab’s technology is intended to provide clinicians with an objective measure to use alongside other examination findings when evaluating tear-film health. Its core business has centered on diagnostic products rather than treatments for eye conditions.

AI Generated. May Contain Errors.

Receive TEAR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TearLab and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TEAR Stock News Headlines

Harrow Announces New Appointments to its Board of Directors
STRATA Skin Science Announces Leadership Change
The investigation Porter spent tens of thousands to document
Porter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experiment called Project Prophet - and documented everything on film. Rooted in the laws of physics, this quantitative approach challenges conventional wealth-building wisdom. With 17 years of verified data behind it, Porter calls it unlike anything he has seen in nearly 30 years in the business.tc pixel
Lawrence schools on 'good footing' financially
Pathway Makes Four Senior Promotions
See More Headlines

TEAR Stock Analysis - Frequently Asked Questions

TearLab's stock was trading at $0.0579 at the start of the year. Since then, TEAR stock has increased by 0.0% and is now trading at $0.0579.

TearLab Corporation (OTCMKTS:TEAR) announced its earnings results on Thursday, August, 8th. The medical research company reported ($0.10) earnings per share (EPS) for the quarter. The medical research company had revenue of $5.85 million for the quarter.

TearLab shares reverse split on the morning of Friday, February 24th 2017.The 1-10 reverse split was announced on Friday, February 24th 2017. The number of shares owned by shareholders was adjusted after the market closes on Thursday, February 23rd 2017. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that TearLab investors own include SCYNEXIS (SCYX), Vislink Technologies (XGTI), Biopharmx (BPMX), Merck & Co., Inc. (MRK), NIKE (NKE), Protalix BioTherapeutics (PLX) and Trevena (TRVN).

Company Calendar

Today
11/21/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Healthcare Equipment & Supplies
Sub-Industry
Healthcare Equipment
Current Symbol
OTCMKTS:TEAR
Previous Symbol
NASDAQ:TEAR
CIK
1299139
Employees
34
Year Founded
2003

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
N/A
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
N/A

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
N/A
Quick Ratio
N/A

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
N/A
Price / Book
N/A

Miscellaneous

Outstanding Shares
N/A
Free Float
N/A
Market Cap
N/A
Optionable
Not Optionable
Beta
N/A

Social Links

The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

This page (OTCMKTS:TEAR) was last updated on 7/9/2020 by MarketBeat.com Staff.
From Our Partners